Unknown

Dataset Information

0

S100A8/A9 mRNA induction in an ex vivo model of endotoxin tolerance: roles of IL-10 and IFN?.


ABSTRACT:

Objectives

Septic syndromes are the leading cause of death in intensive care units. They are characterized by the development of immune dysfunctions such as endotoxin tolerance (ET), whose intensity and duration are associated with increased risk of nosocomial infections and mortality. Alarmins S100A8 and S100A9 have been shown to be increased after septic shock. Importantly, a delayed S100A9 mRNA increase predicts hospital-acquired infection in patients. The aim of this study was to investigate the regulation of S100A8 and S100A9 mRNA expression in an ex vivo model of ET.

Subjects and measurements

ET was reproduced ex vivo by priming healthy peripheral blood mononuclear cells (number of donors ?=?9 to 10) with low-dose endotoxin (2 ng/ml) before stimulation with high dose endotoxin (100 ng/ml). S100A8 and S100A9 mRNA levels were measured by quantitative real-time polymerase chain reactions.

Main results

ET was established by observing decreased TNF? and increased IL-10 transcriptomic responses to two subsequent endotoxin challenges. Interestingly, ET was associated with increased S100A8 and S100A9 mRNA expression ex vivo. We showed that IL-10 played a role in this process, since S100A8 and S100A9 mRNA increases were significantly abrogated by IL-10 blockade in the model. Conversely, treatment with rIFN-?, a pro-inflammatory and immunostimulating molecule known to block ET induction, was able to restore normal S100A8 and S100A9 mRNA in this model.

Conclusions

In this ex vivo model, we observed that S100A8 and S100A9 mRNA expression was significantly increased during ET. This reproduced ex vivo the observations we had previously made in septic shock patients. Interestingly, IL-10 blockade and rIFN-? treatment partially abrogated S100A8/A9 mRNA increases in this model. Pending confirmation in larger, independent clinical studies, these preliminary results suggest that S100A8 and S100A9 mRNA levels might be used as surrogate markers of ET and as stratification tools for personalized immunotherapy in septic shock patients.

SUBMITTER: Fontaine M 

PROVIDER: S-EPMC4067416 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

S100A8/A9 mRNA induction in an ex vivo model of endotoxin tolerance: roles of IL-10 and IFNγ.

Fontaine Mathieu M   Planel Séverine S   Peronnet Estelle E   Turrel-Davin Fanny F   Piriou Vincent V   Pachot Alexandre A   Monneret Guillaume G   Lepape Alain A   Venet Fabienne F  

PloS one 20140623 6


<h4>Objectives</h4>Septic syndromes are the leading cause of death in intensive care units. They are characterized by the development of immune dysfunctions such as endotoxin tolerance (ET), whose intensity and duration are associated with increased risk of nosocomial infections and mortality. Alarmins S100A8 and S100A9 have been shown to be increased after septic shock. Importantly, a delayed S100A9 mRNA increase predicts hospital-acquired infection in patients. The aim of this study was to inv  ...[more]

Similar Datasets

| S-EPMC9898181 | biostudies-literature
| S-EPMC6004386 | biostudies-literature
| S-EPMC2556970 | biostudies-literature
| S-EPMC7762710 | biostudies-literature
| S-EPMC9464401 | biostudies-literature
| S-EPMC5454315 | biostudies-literature
| S-EPMC6231135 | biostudies-literature
| S-EPMC7122461 | biostudies-literature
| S-EPMC8021540 | biostudies-literature
| S-EPMC10653093 | biostudies-literature